Effect of high-performance liquid chromatography on plasma angiotensin II measurements in treated and untreated normotensive and hypertensive patients

Journal of Hypertension

Volumn 15, Issue 5, 1997, Pages 459-465

  Bragat, Alexander C ^a   Blumenfeld, Jon ^a   Sealey, Jean E ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Ang II antagonism; Angiotensin II; High performance liquid chromatography; Hypertension; Normotensive subjects; Radioimmunoassay; adrenergic blockade

Indexed keywords

ANGIOTENSIN; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; IRBESARTAN; POLYCLONAL ANTIBODY; RENIN;

ACCURACY; ANGIOTENSIN BLOOD LEVEL; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; IMMUNOREACTIVITY; LABORATORY TEST; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0030949046     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Sealey JE, Laragh JH: The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium homeostasis. In Hypertension: Pathophysiology, Diagnosis and Management. Edited by Laragh JH, Brenner BM. New York: Raven Press; 1990:1287-1317.
2. Sealey JE, James GD. Laragh JH: Interpretation and guidelines for the use of plasma and urine aldosterone and plasma angiotensin II, angiotensinogen, prorenin, peripheral, and renin vein renin tests. In Hypertension: Pathophysiology, Diagnosis and Management. Edited by Laragh JH, Brenner BM. New York: Raven Press; 1995:1953-1968.
3. Nussberger J, Brunner DB, Waeber B, Brunner HR: True versus immunoreactive angiotensin II in human plasma Hypertension 1985, 7 (part II):11-17.
4. Hermann K, Ganten D, Unger T, Bayer C, Lang RE: Measurement and characterization of angiotensin peptides in plasma. Clin Chem 1988, 34:1046-1051.
5. Simon D, Romestand B, Huang H, Badouaille G, Fahrenty J, Pau B, et al.: Direct simplified, and sensitive assay of angiotensin II in plasma extracts performed with a high-affinity monoclonal antibody. Clin Chem 1992, 38:1963-1967.
6. Kawamura M, Imanishi M, Matsushima Y, Akabane S, Kuramoch M, Ho K, et al.: A comparison of lisinopril with enalapril by monitoring plasma angiotensin II levels in humans. Jap J Pharmacol 1990, 54:143-149.
7. Sealey JE, Trenkwalder P, Gahnem F, Catanzaro DF, Laragh JH: Plasma renin methodology: inadequate sensitivity and accuracy of direct renin assay for clinical applications compared with the traditional enzymatic PRA assay (editorial). J Hypertens 1995, 13:27-30.
8. Jeunemaitre X, Ménard J, Nussberger J, Guyenne TT, Brunner HR, Corvol P: Plasma angiotensins, renin, and blood pressure during acute renin inhibition by CGP 38560A in hypertensive patients Am J Hypertens 1989, 2:819-827.
9. Delacretaz E, Nussberger J, Puchler K, Wood AJ, Robinson PR, Waeber B, et al.: Value of different clinical and biochemical correlates to assess angiotensin converting enzyme inhibition. J Cardiovasc Pharmacol 1994, 24:479-485.
10. Chappell MC, Brosnihan KB, Welches WR, Ferrario CM: Characterization by high performance liquid chromatography of angiotensin peptides in the plasma and cerebrospinal fluid of the dog. Peptides 1987, 8:939-942.
11. Hermann K, Ring J, Phillips MI: High-performance liquid chromatography for the separation of angiotensin and its metabolites in human plasma and sweat J Chromatograph Sci 1990, 28:524-528.
12. Campbell DJ, Kladis A: Simulataneous radioimmunoassay of six angiotensin peptides in artrial and venous plasma of man. J Hypertens 1993, 21:155-165.
13. Nussberger J, Keller I, Waeber B, Brunner HR: Angiotensin II measurement with high-affinity monoclonal antibodies. J Hypertens 1988, 6 (suppl 4):S424-S425.
14. Gocke DJ, Gerten J, Sherwood LM, Laragh JH: Physiological and pathological variations of plasma angiotensin II in man. Correlation with renin activity and sodium balance. Circ Res 1969, 24 (suppl 1):131-146.
15. Nussberger J, Brunner DB, Waeber B, Brunner HR: In vitro inhibition to prevent generation of angiotensins during determination of angiotensin I and II. Life Sci 1995, 42:1683-1688.
16. Sealey JE: Plasma renin activity and plasma prorenin assays Clin Chem 1991, 37:1811-1819.
17. Rodbard D, Munson P, DeLean A: Improved curve fitting, parallelism testing, characterization of sensitivity and specificity, validation and optimization for radioligand assays, radioimmunoassays and related procedures in medicine. International Atomic Energy Agency 1978, 469-514.
18. Nussberger J, Brunner DB, Waeber B, Brunner HR: Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma. Hypertension 1986, 8:476-482.
19. Lachurie ML, Azizi M, Guyene TT, Alhenc-Gelas F, Menard J: Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation 1995, 91:2933-2942.
20. Bragat AC, August P, Cacciabaudo JM, Sealey JE: High Ang II levels in plasma of pregnant women reduced after HPLC: multiple irAng II peaks detected [abstract]. Am J Hypertens 1995, 8:107A.